Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 22.4B | 20.7B | 19.7B | 17.5B |
Cost of revenue | 14.2B | 13.2B | 13.2B | 12.0B |
Gross profit | 8.2B | 7.5B | 6.5B | 5.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 4.9B | 4.3B | 3.4B | 2.4B |
Non operating interest income | ||||
Income | 136.7M | 104.3M | 86.2M | 70.4M |
Expense | 3.5M | 3.6M | 3.6M | 3.9M |
Other income expense | — | — | — | — |
Pretax income | 5.2B | 4.5B | 3.5B | 2.7B |
Tax provision | 1.5B | 1.3B | 1.3B | 806.3M |
Net income | 3.7B | 3.2B | 2.2B | 1.9B |
Basic EPS | — | — | — | 115.4 |
Diluted EPS | — | — | — | 115.4 |
Basic average shares | — | — | — | 16.4M |
Diluted average shares | — | — | — | 16.4M |
EBITDA | 5.2B | 4.4B | 3.6B | 2.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |